ASPE · Forms 3, 4, 5
Insider trades at Aspen Neuroscience
4 insiders bought $68M of Aspen Neuroscience stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Aspen Neuroscience (ASPE) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Peter A. Thompson | Director | Conversion | 196,541 | Form 4 | |||
| Peter A. Thompson | Director | Conversion | 642,745 | Form 4 | |||
| Peter A. Thompson | Director | Conversion | 616,984 | Form 4 | |||
| Peter A. Thompson | Director | Conversion | 625,743 | Form 4 | |||
| Peter A. Thompson | Director | Conversion | 507,119 | Form 4 | |||
| Peter A. Thompson | Director | Buy | 1,000,000 | $15.00 | $15M | Form 4 | |
| ORBIMED ADVISORS LLC | Director | Conversion | 196,541 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Conversion | 642,745 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Conversion | 616,984 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Conversion | 625,743 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Conversion | 507,119 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Buy | 1,000,000 | $15.00 | $15M | Form 4 | |
| ARCH Venture Fund X, L.P. | 10% owner | Buy | 66,666 | $15.00 | $1M | Form 4 | |
| ARCH Venture Fund X, L.P. | 10% owner | Conversion | 187,182 | Form 4 | |||
| ARCH Venture Fund X, L.P. | 10% owner | Conversion | 298,258 | Form 4 | |||
| ARCH Venture Fund X, L.P. | 10% owner | Conversion | 286,304 | Form 4 | |||
| ARCH Venture Fund X, L.P. | 10% owner | Conversion | 295,490 | Form 4 | |||
| ARCH Venture Fund X, L.P. | 10% owner | Conversion | 259,948 | Form 4 | |||
| ARCH Venture Fund X, L.P. | 10% owner | Buy | 66,667 | $15.00 | $1M | Form 4 | |
| ARCH Venture Fund X, L.P. | 10% owner | Conversion | 298,258 | Form 4 | |||
| ARCH Venture Fund X, L.P. | 10% owner | Conversion | 286,304 | Form 4 | |||
| ARCH Venture Fund X, L.P. | 10% owner | Conversion | 295,490 | Form 4 | |||
| ARCH Venture Fund X, L.P. | 10% owner | Conversion | 214,355 | Form 4 | |||
| ARCH Venture Fund X, L.P. | 10% owner | Buy | 1,200,000 | $15.00 | $18M | Form 4 | |
| ARCH Venture Partners XIV, L.P. | 10% owner | Buy | 1,200,000 | $15.00 | $18M | Form 4 | |
| Andrew Spaventa | Director | Conversion | 70,194 | Form 4 | |||
| Andrew Spaventa | Director | Conversion | 180,221 | Form 4 | |||
| Faheem Hasnain | Executive Chair | Conversion | 14,913 | Form 4 | |||
| Faheem Hasnain | Executive Chair | Conversion | 14,316 | Form 4 | |||
| Faheem Hasnain | Executive Chair | Conversion | 7,120 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Became an insider (Form 3) | Form 3 | ||||
| Jeffrey Lee Boerneke | General Counsel and Secretary | Became an insider (Form 3) | Form 3 | ||||
| Andrew Spaventa | Director | Became an insider (Form 3) | Form 3 | ||||
| Faheem Hasnain | Executive Chair | Became an insider (Form 3) | Form 3 | ||||
| ARCH Venture Fund X, L.P. | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Thomas O Daniel | Director | Became an insider (Form 3) | Form 3 | ||||
| Peter A. Thompson | Director | Became an insider (Form 3) | Form 3 | ||||
| Damien McDevitt | Director | Became an insider (Form 3) | Form 3 | ||||
| Douglas Carl Fisher | Director | Became an insider (Form 3) | Form 3 | ||||
| Caryn Peterson | Director | Became an insider (Form 3) | Form 3 | ||||
| Dalen Meeter | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Kim Raineri | Chief Technology Officer | Became an insider (Form 3) | Form 3 | ||||
| Lisa Johnson-Pratt | Chief Commercial Officer | Became an insider (Form 3) | Form 3 | ||||
| Cynthia Dorothy Perettie | Director | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.